Pharmaceutical companies

CCGs failed to declare hundreds of payments from drug companies, BMJ investigation reveals

Clinical commissioning groups in England failed to publicly declare a third of all payments accepted from pharmaceutical companies, the private sector and charities between 2015 and 2017.…

Pharma companies may be less likely to invest in the UK post-Brexit, MPs told

UK patient involvement in clinical trials will diminish post-Brexit making manufactures less likely to want to invest here, MPs on the House of Commons Health Select Committee were told.…

Artificial Intelligence: will it change the way drugs are discovered?

The pharmaceutical industry is beginning to invest in artificial intelligence (AI), with many large pharmaceutical companies partnering with AI start-ups in 2017 in order to develop better diagnostics or biomarkers, to identify drug targets and to design new drugs. But when will the first AI-designe…

LloydsPharmacy to open healthcare centres across England

High street pharmacy chain LloydsPharmacy is to open a series of healthcare centres around England, providing infusion, testing and screening services…

Sildenafil to be reclassified to P medicine

Sildenafil is to be formally reclassified from a prescription only medicine to a pharmacy medicine, the Medicines and Healthcare products Regulatory Agency has announced.…

NHS faces legal action for prescribing cheaper drug off label for sight loss

Two drug companies are threatening legal action against NHS doctors over plans to prescribe a cheaper off-label drug to treat wet age-related macular degeneration. …

Breaches of ABPI code of practice rise sharply, according to report

Breaches to the Association of the British Pharmaceutical Industry (ABPI) code of practice have risen sharply, a report has found.…

Lords hears that Brexit could hit UK life sciences industry

International drug companies are keen to invest in the UK’s life sciences industry provided there is evidence of match funding from the government, members of the House of Lords science and technology committee were told on 24 October 2017.…

The Medical Costs Act — what it means for pharma and pharmacy

Legal expert Andrew Sweetman explains the new Health Service Medical Supplies (Costs) Act and its implications for pharmacy.…

Pharmaceutical firms cut price of cancer drugs for African countries

Two major pharmaceutical companies are to cut the price of cancer drugs to sub-Saharan African countries following a deal brokered by the American Cancer Society and the Clinton Health Access Initiative.…